Apocrine Carcinomas Are a Distinct Subset of Androgen Receptor Positive (AR plus ) Triple Negative Breast Carcinomas (TNBC)

被引：0
|
作者：
Astvatsaturyan, Kristine [1 ]
Yue, Yong [1 ]
Bose, Shikha [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：30A / 30A
页数：1
相关论文
共 50 条
  • [31] Comprehensive profiling of androgen receptor-positive (AR plus ) triple-negative breast cancer (TNBC) patients (pts) treated with standard neoadjuvant therapy (NAT) ± enzalutamide
    Lim, Bora
    Seth, Sahil
    Huo, Lei
    Layman, Rachel M.
    Valero, Vicente
    Thompson, Alastair Mark
    White, Jason B.
    Litton, Jennifer Keating
    Damodaran, Senthil
    Candelaria, Rosalind P.
    Arun, Banu
    Rauch, Gaiane M.
    Murthy, Rashmi Krishna
    Ding, Qingqing
    Symmans, William Fraser
    Zhao, Li
    Zhang, Jianjun
    Tripathy, Debu
    Moulder, Stacy L.
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR plus or Quadruple Negative Disease
    Barton, Valerie N.
    D'Amato, Nicholas C.
    Gordon, Michael A.
    Christenson, Jessica L.
    Elias, Anthony
    Richer, Jennifer K.
    HORMONES & CANCER, 2015, 6 (5-6): : 206 - 213
  • [33] Expression of oestrogen receptor-β in apocrine carcinomas of the breast
    Honma, N.
    Takubo, K.
    Akiyama, F.
    Kasumi, F.
    Sawabe, M.
    Arai, T.
    Hosoi, T.
    Yoshimura, N.
    Harada, N.
    Younes, M.
    Sakamoto, G.
    HISTOPATHOLOGY, 2007, 50 (04) : 425 - 433
  • [34] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    MODERN PATHOLOGY, 2019, 32
  • [35] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    LABORATORY INVESTIGATION, 2019, 99
  • [36] Androgen Receptor Expression in HER2-Positive Breast Carcinomas
    Larson, Alexandra
    Helenowski, Irene B.
    Pincus, Jennifer
    Ubago, Julianne M.
    Rosca, Adriana
    Blanco, Luis Z.
    Siziopikou, Kalliopi P.
    MODERN PATHOLOGY, 2016, 29 : 53A - 53A
  • [37] Androgen Receptor Expression in HER2-Positive Breast Carcinomas
    Larson, Alexandra
    Helenowski, Irene B.
    Pincus, Jennifer
    Ubago, Julianne M.
    Rosca, Adriana
    Blanco, Luis Z.
    Siziopikou, Kalliopi P.
    LABORATORY INVESTIGATION, 2016, 96 : 53A - 53A
  • [38] Androgen receptor (AR) expression in male breast carcinomas (MBC): Prognostic significance
    League, AA
    Gansler, T
    DeRose, PB
    Cohen, C
    LABORATORY INVESTIGATION, 1999, 79 (01) : 25A - 25A
  • [39] Invasive Apocrine Carcinoma of the Breast: Clinicopathologic Features and Comprehensive Genomic Profiling of 18 Pure Triple Negative Apocrine Carcinomas
    Sun, Xiangjie
    Zuo, Ke
    Yang, Wentao
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 272 - 273
  • [40] Invasive Apocrine Carcinoma of the Breast: Clinicopathologic Features and Comprehensive Genomic Profiling of 18 Pure Triple Negative Apocrine Carcinomas
    Sun, Xiangjie
    Zuo, Ke
    Yang, Wentao
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 272 - 273
12345